Consortium for Clinical Research and Innovation Singapore
Ministry of Health, Singapore
Centre of Regulatory Excellence
SingHealth Duke-NUS Global Health Institute
Professor John CW Lim is founding Executive Director of the Centre of Regulatory Excellence (CoRE) at the Duke-National University of Singapore Medical School (Duke-NUS), and Policy Core Lead of the SingHealth Duke-NUS Global Health Institute (SDGHI).
A medical doctor with graduate degrees in Public Health from NUS and Health Policy and Management from Harvard University, Professor Lim is Chairman of the Consortium for Clinical Research and Innovation Singapore (CRIS), Senior Advisor at Singapore’s Ministry of Health (MOH), and Professor of Practice at Duke-NUS and the NUS Saw Swee Hock School of Public Health.
Formerly the Chief Executive Officer of Singapore’s Health Sciences Authority and Deputy Director of Medical Services (Industry & Research Matters) in MOH, Professor Lim has also held other senior positions in the health and education ministries. In his current roles, he draws on his international experience and networks to enhance capacity building and scientific excellence for issues related to health products regulation, health policies, and health systems in Southeast Asia and the Asia-Pacific.
In the current COVID-19 pandemic, he is working with his colleagues in CoRE and SDGHI to provide advice, share knowledge, and facilitate collaborative discussions among international and national stakeholders on relevant issues to promote regulatory cooperation, including vaccines development and access.
In addition, Professor Lim is a member of the Board of the Singapore Food Agency, Executive Board of the APEC Life Sciences Innovation Forum, Advisory Group of the US Pharmacopoeia’s Quality Institute, Scientific Advisory Council of the Centre for Innovation in Regulatory Science, ASEAN Diagnostics Development Initiative Strategic Planning Panel, and St Andrew’s Mission Hospital Board. He also serves on the Leadership Group of the Davos Alzheimer’s Collaborative, led by The World Economic Forum and The Global CEO Initiative on Alzheimer’s Disease.
In 2018, Professor Lim received the Drug Information Association’s Global Connector Inspire Award for leadership in promoting global collaboration to advance healthcare products to patients, and the Regulatory Affairs Professional Society’s highest Founder’s Award recognising substantial sustained impact in shaping regulatory practice and policy throughout his career.